Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlos Martins da Silva

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Clinical Drug Investigation|February 25, 2015
The diagnosis and treatment of lower urinary tract symptoms due to benign prostatic hyperplasia with α-blockers: focus on silodosinJúlio Fonseca, Carlos Martins da Silva
Clinical Drug Investigation|February 25, 2015
The diagnosis and treatment of lower urinary tract symptoms due to benign prostatic hyperplasia by primary care family physicians in PortugalJúlio Fonseca, Carlos Martins da Silva
Current Opinion in Urology|May 16, 2009
Has botulinum toxin therapy come of age: what do we know, what do we need to know, and should we use it?Carlos Martins da Silva, Francisco Cruz
International Journal of Urology : Official Journal of the Japanese Urological Association|May 3, 2013
Botulinum toxin treatment for bladder dysfunctionAndré Santos-Silva, Carlos Martins da Silva, Francisco Cruz
Toxicon : Official Journal of the International Society on Toxinology|August 4, 2015
Use of botulinum toxin for genitourinary conditions: What is the evidence?Carlos Martins da Silva, Michael B Chancellor, Christopher Patrick Smith, et al.
Clinical Drug Investigation|October 20, 2022
Correction to: Nonmetastatic Castration‑Resistant Prostate Cancer: Current Challenges and TrendsArnaldo Figueiredo, Luís Costa, Maria Joaquina Maurício, et al.
Clinical Drug Investigation|July 13, 2022
Nonmetastatic Castration-Resistant Prostate Cancer: Current Challenges and TrendsArnaldo Figueiredo, Luís Costa, Maria Joaquina Maurício, et al.
Clinical Drug Investigation|January 27, 2023
Correction to: Nonmetastatic Castration‑Resistant Prostate Cancer: Current Challenges and TrendsArnaldo Figueiredo, Luís Costa, Maria Joaquina Maurício, et al.
BJU International|April 17, 2012
Androgen deprivation therapy for volume reduction, lower urinary tract symptom relief and quality of life improvement in patients with prostate cancer: degarelix vs goserelin plus bicalutamideKarol Axcrona, Sirpa Aaltomaa, Carlos Martins da Silva, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Clinical Drug Investigation|February 25, 2015
The diagnosis and treatment of lower urinary tract symptoms due to benign prostatic hyperplasia with α-blockers: focus on silodosinJúlio Fonseca, Carlos Martins da Silva
Clinical Drug Investigation|February 25, 2015
The diagnosis and treatment of lower urinary tract symptoms due to benign prostatic hyperplasia by primary care family physicians in PortugalJúlio Fonseca, Carlos Martins da Silva
Current Opinion in Urology|May 16, 2009
Has botulinum toxin therapy come of age: what do we know, what do we need to know, and should we use it?Carlos Martins da Silva, Francisco Cruz
International Journal of Urology : Official Journal of the Japanese Urological Association|May 3, 2013
Botulinum toxin treatment for bladder dysfunctionAndré Santos-Silva, Carlos Martins da Silva, Francisco Cruz
Toxicon : Official Journal of the International Society on Toxinology|August 4, 2015
Use of botulinum toxin for genitourinary conditions: What is the evidence?Carlos Martins da Silva, Michael B Chancellor, Christopher Patrick Smith, et al.
Clinical Drug Investigation|October 20, 2022
Correction to: Nonmetastatic Castration‑Resistant Prostate Cancer: Current Challenges and TrendsArnaldo Figueiredo, Luís Costa, Maria Joaquina Maurício, et al.
Clinical Drug Investigation|July 13, 2022
Nonmetastatic Castration-Resistant Prostate Cancer: Current Challenges and TrendsArnaldo Figueiredo, Luís Costa, Maria Joaquina Maurício, et al.
Clinical Drug Investigation|January 27, 2023
Correction to: Nonmetastatic Castration‑Resistant Prostate Cancer: Current Challenges and TrendsArnaldo Figueiredo, Luís Costa, Maria Joaquina Maurício, et al.
BJU International|April 17, 2012
Androgen deprivation therapy for volume reduction, lower urinary tract symptom relief and quality of life improvement in patients with prostate cancer: degarelix vs goserelin plus bicalutamideKarol Axcrona, Sirpa Aaltomaa, Carlos Martins da Silva, et al.
Pageof 1